eGFR (Estimated Glomerular Filtration Rate): Normal Range, Non-African American vs. African American Values, and What Your Result Means

WHAT IS eGFR?

If your lab report shows "eGFR," "eGFR (Non-African American)," or "eGFR (African American)" — 4 things to know:

1. eGFR is an estimate, not a direct measurement — it's calculated from a creatinine blood test plus your age and sex, not measured directly
2. One low result does not diagnose CKD — chronic kidney disease requires reduced function sustained over three months or more
3. Age changes what's considered normal — an eGFR in the 70s is often entirely expected for someone over 65–70, while the same number in a 30-year-old warrants more attention
4. Urine albumin is just as important as eGFR — kidney damage can show up in urine protein testing before eGFR drops at all

Quick interpretation:

eGFR (estimated glomerular filtration rate) measures how much blood your kidneys filter per minute. Your kidneys' main job is removing waste and excess water from blood to make urine; the glomeruli — tiny filtering units inside each kidney — are what actually perform this filtration. eGFR is calculated, not directly measured: a true measured GFR (mGFR) requires injecting a tracer substance and timing its clearance, which is accurate but impractical for routine use. Instead, labs estimate GFR using a formula based on blood creatinine, age, and sex. Creatinine is a waste product from normal muscle breakdown and dietary protein digestion; because the kidneys are responsible for clearing it, elevated creatinine signals reduced filtration capacity, and the eGFR formula converts that creatinine level into an estimated filtration rate.

Why "estimated"? Measuring true GFR directly requires injecting a filtration marker (such as iohexol or inulin) and tracking its clearance rate over several hours — accurate, but far too involved for routine screening. The estimated version uses a validated mathematical formula instead, trading some precision for practicality. For most patients, eGFR is reliable; it becomes less accurate in people under 18, during pregnancy, and in those with significantly higher or lower than average muscle mass (since creatinine production is tied to muscle mass).

WHY DOES MY LAB REPORT SHOW TWO eGFR VALUES — "AFRICAN AMERICAN" AND "NON-AFRICAN AMERICAN"?

This is the single most common question about eGFR results, and the reason many people end up on this page. If your report shows two separate numbers — one labeled "African American" and one "Non-African American" (or "Non-AA") — here is what that means and why it happened.

The history: Until 2021, the standard eGFR equations (MDRD and CKD-EPI) included a race-based correction factor. Clinical studies had found that, on average, individuals who self-identified as Black or African American had somewhat higher measured creatinine levels for a given true GFR, a difference researchers attributed at the time to differences in average muscle mass and creatinine metabolism. Because a patient's self-identified race is not always recorded or available at the time labs run the test, many laboratories began reporting both possible values side by side — one calculated with the race coefficient applied, one without — so that whichever applied to the patient could be selected.

Why this changed: The use of race as a biological variable in this calculation became the subject of significant clinical and ethical debate. Race is a social construct, not a discrete biological category, and using it as a calculation input did not account for the genetic and physiological diversity within any racial group, nor did it have a clear answer for multiracial patients. Critics argued that the race-based formula could systematically overestimate kidney function in Black patients, potentially delaying diagnosis, specialist referral, transplant eligibility, and dialysis planning.

What happened next: In 2021, a joint task force convened by the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) formally recommended adopting a new, race-free equation — the 2021 CKD-EPI creatinine equation — and recommended that laboratories nationwide stop reporting race-based eGFR values. This recommendation has been widely adopted: most major US laboratories have transitioned to the single race-free 2021 CKD-EPI equation. If your lab report still shows two separate race-based values, it most likely reflects either an older report (from before your lab's transition) or a laboratory that has not yet fully updated its reporting system.

What this means for your result: If you have an older report showing two values, the "Non-African American" value was traditionally used for patients who do not identify as Black/African American, and the "African American" value (which was typically calculated as somewhat higher for the same creatinine level) was used for those who do. If you're unsure which applies to you, or if your more recent labs only show a single race-free value, that single value is the current standard and the one your care team should be using going forward. The race-free 2021 CKD-EPI equation does not require you to specify a race at all.

Is the race-free version less accurate? Research comparing the two approaches has found the race-free 2021 CKD-EPI equation performs comparably overall, with the specific advantage of eliminating a source of systematic bias that disadvantaged Black patients under the older formula. It is now the standard recommended equation in US clinical guidelines.

If your current lab report shows only a single eGFR value, that's expected — most laboratories now report only the race-free 2021 CKD-EPI result, and you don't need to do anything differently with it.

"MY eGFR IS X" — INDIVIDUAL VALUE LOOKUP

Should I worry?

A single low result is not a diagnosis. Chronic kidney disease is defined by reduced eGFR (or other evidence of kidney damage) persisting for three months or longer — not a single test result. Creatinine, and therefore eGFR, can be temporarily affected by dehydration, recent intense exercise, a high-protein meal shortly before testing, certain medications, and acute illness. If your eGFR comes back lower than expected, the standard next step is simply to repeat the test, not to assume a diagnosis from one value.

Two examples showing why the same number can mean different things:

Case 1 — Age 72, creatinine 1.0, eGFR 74, urine albumin normal. Interpretation: likely normal age-related decline. An eGFR in the mid-70s is close to the population average for someone in their 70s, and with no protein in the urine, there's no additional evidence of kidney damage. Routine monitoring is reasonable; this pattern alone doesn't point toward CKD.

Case 2 — Age 34, creatinine 1.0, eGFR 74, urine albumin elevated. Interpretation: needs investigation. The identical eGFR of 74 is well below the expected average for someone in their 30s, and the elevated urine albumin adds a second piece of evidence pointing toward real kidney involvement rather than simple age-related decline. This combination — using the eGFR + UACR framework above — warrants a closer look: repeat testing, blood pressure check, diabetes screening, and likely a primary care or nephrology follow-up.

Same eGFR number. Very different clinical pictures, once age and urine albumin are factored in.

NORMAL eGFR RANGE BY AGE

eGFR naturally declines with age, even in people with no kidney disease at all — this is a normal physiological pattern, not evidence of a problem on its own.

These are population averages, not cutoffs for diagnosis — an eGFR in the 70s is often entirely normal and expected in a healthy 75-year-old, while the same number in a 30-year-old would warrant further evaluation. Age, alongside other risk factors and trend over time, is essential context for interpreting any single eGFR result.

Why the same number means different things at different ages:

• Age 75, eGFR ≈ 75: Close to the population average for that age group. Usually not CKD by itself, and not typically a cause for alarm in isolation.
• Age 30, eGFR 75: The same number, but well below the expected average for that age. This is worth investigating — repeat testing, urine albumin, and a look at risk factors like blood pressure and blood sugar are reasonable next steps.

The number alone doesn't tell the whole story; the number relative to what's expected for that person's age does.

WHAT DOES HIGH eGFR MEAN?

An eGFR above the typical normal range is less commonly discussed than a low result, but is a real and clinically relevant finding.

Hyperfiltration: An elevated eGFR can reflect a state called glomerular hyperfiltration, in which the kidneys are filtering blood at an abnormally rapid rate. This is most commonly seen in early diabetes (particularly before other diabetic complications appear), obesity, and pregnancy. Hyperfiltration is associated with increased cardiovascular risk in the populations where it's most common, and over the long term may itself predispose to glomerular damage and a subsequent decline in kidney function — though it is not yet fully established whether hyperfiltration directly causes this damage or is simply a marker that travels alongside other risk factors.

Other causes of a high eGFR result: young age and high muscle mass (since the eGFR formula is calibrated to population averages, very muscular individuals can show artificially high eGFR due to higher baseline creatinine production being offset incorrectly by the formula), recent high protein intake before testing in some formula variants, and pregnancy (kidney filtration genuinely increases during pregnancy).

When to be concerned: An isolated high eGFR in an otherwise healthy person is rarely an emergency finding. It becomes more clinically relevant in the context of diabetes or obesity, where it may be an early signal worth discussing with your physician as part of broader cardiovascular and kidney risk assessment.

WHAT DOES LOW eGFR MEAN?

A low eGFR means your kidneys are filtering blood less effectively than expected for your age and sex.

Common causes of low eGFR:

Symptoms of reduced kidney function: Early-stage kidney disease typically causes no symptoms at all, which is why eGFR screening matters — by the time symptoms appear, significant kidney function has often already been lost. When symptoms do appear, they can include dry and persistently itchy skin, muscle cramps, swollen ankles and feet, changes in urination frequency, foamy or bloody urine, sleep problems, fatigue, difficulty concentrating, nausea, poor appetite, and high blood pressure.

Is this temporary or chronic? A simple pathway:

1. Low eGFR on one test? → Repeat the test in 2–4 weeks, ideally well-hydrated and without recent intense exercise or NSAID use beforehand
2. Did it recover to normal? → Likely temporary — dehydration, recent illness, or a medication effect was probably responsible
3. Still low on repeat testing? → Check urine albumin-to-creatinine ratio and blood pressure
4. Persisting beyond three months, with or without other evidence of kidney damage? → Meets the criteria for chronic kidney disease evaluation and staging

This is essentially the same logic a nephrologist applies when a patient presents with an unexpectedly low eGFR — rule out the reversible, common explanations first, and only treat the finding as chronic once it has genuinely persisted.

CKD STAGES — UNDERSTANDING YOUR RESULT

Stage assignment requires sustained results over time, not a single test — and stages 1 and 2 specifically require additional evidence of kidney damage (such as protein in the urine) beyond eGFR alone, since an eGFR of 60–89 can be entirely normal in an older adult with no other signs of kidney disease.

How CKD typically progresses, using diabetes as an example:

1. Early diabetes — blood sugar elevated, kidneys not yet damaged
2. Hyperfiltration — kidneys initially filter faster than normal in response to high blood sugar (see "What does high eGFR mean" above)
3. Microalbuminuria — small amounts of protein begin leaking into urine, often before eGFR itself starts declining; this is frequently the earliest detectable sign of kidney involvement
4. Declining eGFR — filtration capacity begins to drop as cumulative damage to the kidney's filtering units progresses
5. Advanced CKD — substantial, often irreversible loss of kidney function

This progression is why urine albumin testing is recommended alongside eGFR rather than as a replacement for it — by the time eGFR itself starts falling, kidney damage may already be at a more advanced stage than someone watching eGFR alone would assume.

eGFR AND URINE ALBUMIN TOGETHER — HOW SPECIALISTS ACTUALLY ASSESS RISK

Kidney specialists don't classify CKD by eGFR alone. They combine eGFR with urine albumin (measured as UACR, the urine albumin-to-creatinine ratio), because someone with an eGFR of 70 and significant albuminuria may carry a higher long-term risk than someone with an eGFR of 55 and no albuminuria at all. Filtration rate and albumin leakage capture different aspects of kidney health, and looking at either one alone misses real risk that the other reveals.

This two-marker approach is the basis of the KDIGO (Kidney Disease: Improving Global Outcomes) risk classification used by nephrologists worldwide — rather than relying on eGFR's single number, it places a patient's risk on a grid combining both eGFR category and albuminuria category, since the two together predict outcomes (progression to kidney failure, cardiovascular risk) far better than either alone. If you have a UACR result alongside your eGFR, reading them together using the table above gives a meaningfully more complete picture than either number in isolation.

eGFR AND CREATININE — HOW THEY RELATE

eGFR is calculated from creatinine, not measured independently — understanding this relationship helps explain why eGFR can sometimes seem inconsistent with how you feel.

Creatinine is a waste product generated by normal muscle metabolism. Because muscle mass varies significantly between individuals, creatinine levels alone are not a reliable kidney function marker without adjustment — a very muscular person and a person with low muscle mass can have the same kidney function but different creatinine levels simply due to differing muscle mass. The eGFR formula attempts to correct for this using age and sex as proxies for typical muscle mass, which is why eGFR is generally a more useful clinical marker than raw creatinine alone, though it is not perfect for people whose body composition is far from average (bodybuilders, individuals with muscle-wasting conditions, amputees).

Cystatin C as an alternative: Some labs offer eGFR calculated from cystatin C, a protein produced by nearly all cells in the body at a fairly constant rate, rather than creatinine. Because cystatin C is much less affected by muscle mass, diet, and physical activity than creatinine, cystatin C-based eGFR can be more accurate in people whose body composition makes creatinine-based eGFR less reliable — very muscular individuals, those with significant muscle loss, amputees, and some older adults. Combining both creatinine-based and cystatin C-based eGFR (sometimes reported as eGFR-cr-cys) is considered the most accurate non-invasive estimate currently available and is increasingly used when creatinine-based results are ambiguous or don't match the clinical picture.

WHEN eGFR AND CREATININE SEEM TO DISAGREE

Because eGFR is calculated from creatinine, the two should generally move in opposite directions together — rising creatinine should mean falling eGFR, and vice versa. When they seem inconsistent with each other or with how someone feels, there's usually a specific explanation.

"My creatinine is normal but my eGFR is flagged low." This is less contradictory than it sounds — the eGFR formula doesn't use creatinine alone, it adjusts creatinine by age and sex. A creatinine value that sits comfortably within the general reference range can still translate into a below-90 eGFR in an older patient, because the formula expects older adults to have somewhat lower creatinine for normal kidney function, given typically lower average muscle mass. The creatinine "normal range" printed on a lab report is usually a single range for all adults; the eGFR calculation is more individualized.

"My creatinine is high but my eGFR looks normal." This is most common in younger, more muscular individuals. Since creatinine comes from muscle metabolism, someone with above-average muscle mass naturally produces more creatinine even with perfectly normal kidney function — the eGFR formula's age and sex adjustment doesn't fully correct for unusually high muscle mass, which can result in a creatinine flagged as "high" while eGFR still calculates as normal or near-normal.

Why this happens — the short version: Sex affects the formula because, on average, men have higher muscle mass and therefore higher baseline creatinine than women for the same true kidney function. Age affects it because muscle mass and metabolism both decline gradually over time. Neither sex nor age is a perfect proxy for actual muscle mass in a specific individual, which is exactly why the discrepancies above occur, and exactly why cystatin C-based eGFR — which doesn't depend on muscle mass at all — can resolve the disagreement when it matters clinically.

CYSTATIN C — WHEN SHOULD IT BE ORDERED?

Cystatin C-based eGFR is not routinely ordered for everyone — creatinine-based eGFR remains the standard first-line test. But in specific populations, where body composition makes creatinine an unreliable proxy for kidney function, cystatin C-based or combined eGFR-cr-cys testing meaningfully improves accuracy.

Populations where cystatin C is particularly useful:

In any of these situations, a creatinine-based eGFR that seems inconsistent with the overall clinical picture — too low in a healthy athlete, or unexpectedly normal in someone with risk factors for kidney disease — is a reasonable trigger to ask about adding cystatin C, either alone or combined with creatinine, for a more individualized result.

HOW MEDICATIONS AND SUPPLEMENTS AFFECT eGFR

If your eGFR changed after starting a new medication, this table is a reasonable starting point for understanding whether the change is expected, reversible, or worth discussing further with your prescriber — particularly with trimethoprim and creatine, where the "change" is actually a lab interference rather than a true change in kidney function.

WHAT CHANGES eGFR QUICKLY?

eGFR, via creatinine, can shift meaningfully within hours to days — far faster than actual kidney damage develops or heals. Understanding this helps distinguish a lab-day fluctuation from a real trend.

A single eGFR drawn shortly after a hard workout, a bout of stomach illness, or a day of poor fluid intake may not reflect your baseline kidney function at all.

What lowers eGFR without indicating real kidney disease?

THE TREND MATTERS MORE THAN ANY SINGLE RESULT

A fall from 110 to 80 may deserve more attention than someone who has been stable at 72 for ten years.

This is one of the most important — and most frequently overlooked — principles in interpreting eGFR. A single number, viewed in isolation, tells you far less than the same number viewed alongside your own history. A steep, recent decline (even one that lands within the "normal" range) is often a more meaningful clinical signal than a number that's been mildly low but stable for years. If you have past eGFR results available, comparing your current value to your own trend — not just the population reference range — is one of the most useful things you can do before deciding how concerned to be.

How often should eGFR be repeated?

NEXT TESTS AFTER ABNORMAL eGFR

If eGFR is LOW:

If eGFR is HIGH:

COMMON eGFR INTERPRETATION MISTAKES

Mistake 1: eGFR below 90 doesn't automatically mean kidney disease. A large share of healthy adults — particularly anyone over 50 — have an eGFR somewhat below 90 with no kidney disease at all. Age-related decline is normal, not pathological, on its own.

Mistake 2: One low result isn't CKD. A value drawn during illness, dehydration, or shortly after intense exercise should be repeated before drawing conclusions — see the temporary-vs-chronic pathway above.

Mistake 3: Older adults naturally have lower eGFR — that's expected, not a red flag by itself. Comparing an older adult's eGFR against a young, healthy reference range without accounting for normal age-related decline leads to unnecessary alarm.

Mistake 4: Creatinine and eGFR should never be interpreted separately. Since eGFR is calculated from creatinine, looking at one without the context of the other — and without knowing whether muscle mass, diet, or medications might be skewing creatinine — misses important context (see "When eGFR and Creatinine Seem to Disagree" above).

Mistake 5: Urine albumin is just as important as eGFR, and is sometimes more sensitive. Kidney damage from diabetes, in particular, often shows up in urine protein testing before eGFR itself starts to decline. An eGFR-only evaluation can miss early kidney involvement that urine testing would have caught.